Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_1
7
88%

Phase Distribution

7

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
7(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 1

Trials by Phase

Phase 17 (100.0%)

Trials by Status

terminated113%
unknown113%
completed675%

Recent Activity

0 active trials
Showing 5 of 8
unknown

Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

NCT04132115
completedphase_1

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

NCT01026558
completedphase_1

Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease

NCT01030731
terminatedphase_1

Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia

NCT00771719
completedphase_1

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

NCT01026740
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04132115

Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

Unknown
NCT01026558Phase 1

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

Completed
NCT01030731Phase 1

Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease

Completed
NCT00771719Phase 1

Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia

Terminated
NCT01026740Phase 1

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

Completed
NCT00771524Phase 1

Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone

Completed
NCT00965042Phase 1

Effect of Ceftobiprole on Human Intestinal Microflora

Completed
NCT01026636Phase 1

A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8